International Journal of Drug Policy
Volume 20, Issue 1 , Pages 4-13, January 2009

Drugscapes and the role of place and space in injection drug use-related HIV risk environments

  • Barbara Tempalski

      Affiliations

    • National Development and Research Institutes, Inc., 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 212 845 4474; fax: +1 917 438 0894.
  • ,
  • Hilary McQuie

      Affiliations

    • Regional Director of Harm Reduction Coalition, Oakland, CA, USA

Received 3 July 2007; received in revised form 22 January 2008; accepted 6 February 2008. published online 13 June 2008.

Abstract 

Although considerable research has been conducted to identify the behavioural characteristics that predispose individuals to inject drugs or become infected with HIV via injection drug use, much less research has been conducted on structural and policy determinants, cultural norms, stigma, and ecological factors which may affect drug use risk behaviour, users’ networks and HIV rates associated with drug use across geographic areas. For programme planners, whether official or grassroots, an understanding of place-based characteristics can help better identify risk environments to injection drug use-related HIV, and determine how to facilitate actions regarding public policy and harm reduction to aid in the reduction of risk. As such, we consider in this commentary the importance of geographic place and the socio-spatial and political processes related to place that may help determine where IDU-related HIV risk environments occur.

Keywords: Drugscapes, Place, HIV, Risk environments, Injection drug use, Socio-spatial

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0955-3959(08)00033-9

doi:10.1016/j.drugpo.2008.02.002

International Journal of Drug Policy
Volume 20, Issue 1 , Pages 4-13, January 2009